SLN (Silence Therapeutics Plc American Depository Share)

Insider Trading Activity

Every open-market purchase and sale reported by SLN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
41
most recent
Open-Market Buys
24
code P
Sales
1
code S
Reporting Insiders
0
current holders
SLN — Recent Form 4 Transactions (latest 2026-07-07)
FiledInsiderRole TypeSharesValue
2026-07-07 Richard Ian Griffiths 10%+ Owner Sell
2026-02-13 Richard Ian Griffiths 10%+ Owner MIXED
2026-01-06 James Ede-Golightly Director A
2026-01-06 TIMOTHY MCINERNEY Director A
2026-01-06 RHONDA LYNETTE HELLUMS Chief Financial Officer A
2026-01-06 David Lemus Director A
2026-01-06 Steven J. Romano EVP and Chief R&D Officer A
2025-12-22 Iain Ross Interim PEO A
2025-12-22 James Ede-Golightly Director A
2025-08-04 Richard Ian Griffiths 10%+ Owner Buy
2025-07-31 Richard Ian Griffiths 10%+ Owner Buy
2025-07-23 Richard Ian Griffiths 10%+ Owner Buy
2025-07-16 Richard Ian Griffiths 10%+ Owner Buy
2025-07-10 Richard Ian Griffiths 10%+ Owner Buy
2025-06-30 Richard Ian Griffiths 10%+ Owner Buy
2025-06-25 Richard Ian Griffiths 10%+ Owner Buy
2025-06-20 Richard Ian Griffiths 10%+ Owner Buy
2025-06-13 Richard Ian Griffiths 10%+ Owner Buy
2025-05-29 Richard Ian Griffiths 10%+ Owner Buy
2025-05-27 Richard Ian Griffiths 10%+ Owner Buy
2025-05-21 Richard Ian Griffiths 10%+ Owner Buy
2025-05-20 TIMOTHY MCINERNEY Director A
2025-05-15 Richard Ian Griffiths 10%+ Owner Buy
2025-05-08 Richard Ian Griffiths 10%+ Owner Buy
2025-05-02 Richard Ian Griffiths 10%+ Owner Buy
2025-04-30 Richard Ian Griffiths 10%+ Owner Buy
2025-04-28 Richard Ian Griffiths 10%+ Owner Buy
2025-04-24 Richard Ian Griffiths 10%+ Owner Buy
2025-04-22 Richard Ian Griffiths 10%+ Owner Buy
2025-04-15 Richard Ian Griffiths 10%+ Owner Buy
2025-04-01 Richard Ian Griffiths 10%+ Owner Buy
2025-03-31 Richard Ian Griffiths 10%+ Owner Buy
2025-03-06 Richard Ian Griffiths 10%+ Owner Buy
2025-02-25 Richard Ian Griffiths 10%+ Owner Buy
2025-01-06 James Ede-Golightly Director A
2025-01-06 Iain Ross Director A
2025-01-06 CRAIG A TOOMAN President and CEO A
2025-01-06 David Lemus Director A
2025-01-06 RHONDA LYNETTE HELLUMS Chief Financial Officer A
2025-01-06 Steven J. Romano EVP and Chief R&D Officer A
2025-01-06 Michael H. Davidson Director A
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the SLN quote page; the site-wide leaderboard is on the insider transactions hub.